- Home
- BMR vs VNRX Comparison
BMR vs VNRX Comparison
Compare BMR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMR | VNRX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 38.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMR | VNRX |
|---|---|---|
| Price | $1.97 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 87.6K | ★ 3.3M |
| Earning Date | 08-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,131,000.00 | $1,472,007.00 |
| Revenue This Year | $21.21 | $55.33 |
| Revenue Next Year | N/A | $493.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.96 | ★ 14.48 |
| 52 Week Low | $1.86 | $0.23 |
| 52 Week High | $6.59 | $0.94 |
Technical Indicators
Market Signals| Indicator | BMR | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 38.07 |
| Support Level | $2.18 | $0.23 |
| Resistance Level | $2.21 | $0.30 |
| Average True Range (ATR) | 0.17 | 0.03 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 8.08 | 35.93 |
Price Performance
Historical ComparisonAbout BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.